Odyssey Health (ODYY) Free Cash Flow (2014 - 2026)
Odyssey Health's (ODYY) quarterly Free Cash Flow came in at -$318521.0 in Q2 2026, down 7861.03% year-on-year from $4104.1 in Q2 2025, and down 12.05% quarter-over-quarter from -$284259.0 in Q1 2026.
Odyssey Health (ODYY) Free Cash Flow (2014 - 2026) Analysis & Trends
Odyssey Health's Free Cash Flow history runs 13 years deep, the most recent figure standing at -$318521.0 for Q2 2026.
- On a quarterly basis, Free Cash Flow fell 7861.03% year-over-year to -$318521.0 in Q2 2026; TTM through Apr 2026 was -$934977.0, a 157.69% decrease from a year earlier, with the FY2025 full-year figure at -$347392.0, up 71.41% from the prior year.
- Free Cash Flow fell to -$318521.0 in Q2 2026 per ODYY's latest filing, from -$284259.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $1.1 million in Q3 2022 and bottomed at -$970018.0 in Q2 2022.
- The 5-year median for Free Cash Flow is -$216323.5 (2024), against an average of -$235644.4.
- Across the five-year window, Free Cash Flow jumped 251.16% in 2022 and sank 7861.03% in 2026, its largest moves.
- Year by year, Free Cash Flow stood at -$292745.0 in 2022, then soared by 79.54% to -$59907.0 in 2023, then tumbled by 314.83% to -$248514.0 in 2024, then dropped by 14.28% to -$283998.0 in 2025, then decreased by 12.16% to -$318521.0 in 2026.
- Per Business Quant, the three latest ODYY Free Cash Flow figures stand at -$318521.0 (Q2 2026), -$284259.0 (Q1 2026), and -$283998.0 (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | -318,521.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -318,521.00 |
| Apr 30, 2026 | -318,521.00 |
| Jan 31, 2026 | -284,259.00 |
| Jan 31, 2026 | -284,259.00 |
| Oct 31, 2025 | -283,998.00 |
| Oct 31, 2025 | -283,998.00 |
| Jul 31, 2025 | -48,199.00 |
| Jul 31, 2025 | -48,199.00 |
| Apr 30, 2025 | -4,001.00 |
| Apr 30, 2025 | -4,001.00 |
| Jan 31, 2025 | -46,678.00 |
| Jan 31, 2025 | -46,678.00 |
| Oct 31, 2024 | -248,514.00 |
| Oct 31, 2024 | -248,514.00 |
| Jul 31, 2024 | -63,635.00 |
| Jul 31, 2024 | -63,635.00 |
| Apr 30, 2024 | -184,133.00 |
| Apr 30, 2024 | -184,133.00 |
| Jan 31, 2024 | -907,535.00 |
| Jan 31, 2024 | -907,535.00 |